Ibrutinib for the Prevention of Chronic Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant

Conditions: Chronic Graft Versus Host Disease; Hematopoietic and Lymphatic System Neoplasm Interventions: Procedure: Biospecimen Collection; Procedure: Echocardiography; Drug: Ibrutinib Sponsors: Mayo Clinic Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials